BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Morán L, Cubero FJ. Extracellular vesicles in liver disease and beyond. World J Gastroenterol 2018; 24(40): 4519-4526 [PMID: 30386101 DOI: 10.3748/wjg.v24.i40.4519] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Ajoolabady A, Aslkhodapasandhokmabad H, Zhou Y, Ren J. Epigenetic modification in alcohol‐related liver diseases. Medicinal Research Reviews. [DOI: 10.1002/med.21881] [Reference Citation Analysis]
2 D'Agnano I, Berardi AC. Extracellular Vesicles, A Possible Theranostic Platform Strategy for Hepatocellular Carcinoma-An Overview. Cancers (Basel) 2020;12:E261. [PMID: 31973229 DOI: 10.3390/cancers12020261] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
3 He C, Jaffar Ali D, Aseervatham G SB, Sun B, Xiao Z. Microvesicles - promising tiny players' of cancer stem cells targeted liver cancer treatments: The interesting interactions and therapeutic aspects. Pharmacol Res 2021;169:105609. [PMID: 33852962 DOI: 10.1016/j.phrs.2021.105609] [Reference Citation Analysis]
4 Dhama K, Latheef SK, Dadar M, Samad HA, Munjal A, Khandia R, Karthik K, Tiwari R, Yatoo MI, Bhatt P, Chakraborty S, Singh KP, Iqbal HMN, Chaicumpa W, Joshi SK. Biomarkers in Stress Related Diseases/Disorders: Diagnostic, Prognostic, and Therapeutic Values. Front Mol Biosci 2019;6:91. [PMID: 31750312 DOI: 10.3389/fmolb.2019.00091] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 10.3] [Reference Citation Analysis]
5 Villanueva-Paz M, Morán L, López-Alcántara N, Freixo C, Andrade RJ, Lucena MI, Cubero FJ. Oxidative Stress in Drug-Induced Liver Injury (DILI): From Mechanisms to Biomarkers for Use in Clinical Practice. Antioxidants (Basel) 2021;10:390. [PMID: 33807700 DOI: 10.3390/antiox10030390] [Reference Citation Analysis]
6 Teschke R, Uetrecht J. Mechanism of idiosyncratic drug induced liver injury (DILI): unresolved basic issues. Ann Transl Med 2021;9:730. [PMID: 33987428 DOI: 10.21037/atm-2020-ubih-05] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Lim CZJ, Zhang L, Zhang Y, Sundah NR, Shao H. New Sensors for Extracellular Vesicles: Insights on Constituent and Associated Biomarkers. ACS Sens 2020;5:4-12. [DOI: 10.1021/acssensors.9b02165] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
8 Materón EM, Miyazaki CM, Carr O, Joshi N, Picciani PH, Dalmaschio CJ, Davis F, Shimizu FM. Magnetic nanoparticles in biomedical applications: A review. Applied Surface Science Advances 2021;6:100163. [DOI: 10.1016/j.apsadv.2021.100163] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 5.0] [Reference Citation Analysis]
9 Lee J, Kim SR, Lee C, Jun YI, Bae S, Yoon YJ, Kim OY, Gho YS. Extracellular vesicles from in vivo liver tissue accelerate recovery of liver necrosis induced by carbon tetrachloride. J Extracell Vesicles 2021;10:e12133. [PMID: 34401049 DOI: 10.1002/jev2.12133] [Reference Citation Analysis]
10 Srinivas AN, Suresh D, Santhekadur PK, Suvarna D, Kumar DP. Extracellular Vesicles as Inflammatory Drivers in NAFLD. Front Immunol 2020;11:627424. [PMID: 33603757 DOI: 10.3389/fimmu.2020.627424] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
11 Pandyarajan V, Govalan R, Yang JD. Risk Factors and Biomarkers for Chronic Hepatitis B Associated Hepatocellular Carcinoma. Int J Mol Sci 2021;22:E479. [PMID: 33418899 DOI: 10.3390/ijms22020479] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
12 Cabiati M, Salvadori C, Basta G, Del Turco S, Aretini P, Cecchettini A, Del Ry S. miRNA and long non-coding RNA transcriptional expression in hepatocellular carcinoma cell line-secreted extracellular vesicles. Clin Exp Med 2021. [PMID: 34319456 DOI: 10.1007/s10238-021-00744-6] [Reference Citation Analysis]
13 Newman LA, Sorich MJ, Rowland A. Role of Extracellular Vesicles in the Pathophysiology, Diagnosis and Tracking of Non-Alcoholic Fatty Liver Disease. J Clin Med 2020;9:E2032. [PMID: 32610455 DOI: 10.3390/jcm9072032] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
14 Kim HY, Kwon S, Um W, Shin S, Kim CH, Park JH, Kim BS. Functional Extracellular Vesicles for Regenerative Medicine. Small 2022;:e2106569. [PMID: 35322545 DOI: 10.1002/smll.202106569] [Reference Citation Analysis]
15 Ma J, Shi X, Li M, Chen S, Gu Q, Zheng J, Li D, Wu S, Yang H, Li X. MicroRNA-181a–2–3p shuttled by mesenchymal stem cell-secreted extracellular vesicles inhibits oxidative stress in Parkinson’s disease by inhibiting EGR1 and NOX4. Cell Death Discov 2022;8. [DOI: 10.1038/s41420-022-00823-x] [Reference Citation Analysis]
16 Hernández A, Arab JP, Reyes D, Lapitz A, Moshage H, Bañales JM, Arrese M. Extracellular Vesicles in NAFLD/ALD: From Pathobiology to Therapy. Cells 2020;9:E817. [PMID: 32231001 DOI: 10.3390/cells9040817] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 5.5] [Reference Citation Analysis]
17 Glaser T, Baiocchi L, Zhou T, Francis H, Lenci I, Grassi G, Kennedy L, Liangpunsakul S, Glaser S, Alpini G, Meng F. Pro-inflammatory signalling and gut-liver axis in non-alcoholic and alcoholic steatohepatitis: Differences and similarities along the path. J Cell Mol Med. 2020;24:5955-5965. [PMID: 32314869 DOI: 10.1111/jcmm.15182] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]